These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

369 related items for PubMed ID: 7857756

  • 1. [Epidemiology of arterial hypertension and organ damage].
    Licata G.
    Ann Ital Med Int; 1994 Oct; 9 Suppl():44S-49S. PubMed ID: 7857756
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Influence of metabolic syndrome on hypertension-related target organ damage.
    Mulè G, Nardi E, Cottone S, Cusimano P, Volpe V, Piazza G, Mongiovì R, Mezzatesta G, Andronico G, Cerasola G.
    J Intern Med; 2005 Jun; 257(6):503-13. PubMed ID: 15910554
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Proportion of isolated clinical hypertension in primary care settings. Comparison of target organ damage in patients with isolated clinical hypertension and patients with sustained arterial hypertension.
    Boreu QF, de Tuero GC, Rodríguez-Poncelas A, Albertos MS, Zafra MS, Radó MA, Vampahica Study Group.
    Blood Press; 2007 Jun; 16(6):354-61. PubMed ID: 17852096
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Age and target organ damage in essential hypertension: role of the metabolic syndrome.
    Cuspidi C, Meani S, Valerio C, Sala C, Fusi V, Zanchetti A, Mancia G.
    Am J Hypertens; 2007 Mar; 20(3):296-303. PubMed ID: 17324743
    [Abstract] [Full Text] [Related]

  • 12. [Incidence of the most frequent complications in hypertensive patients].
    Nami R, Carletti F, Panza F, Buracchi P, Martinelli M, Pavese G, Gennari C.
    Minerva Cardioangiol; 1990 Nov; 38(11):479-86. PubMed ID: 2093850
    [Abstract] [Full Text] [Related]

  • 13. [Left ventricular hypertrophy in the Spanish hypertensive population. The ERIC-HTA study].
    Lozano JV, Redón J, Cea-Calvo L, Fernández-Pérez C, Navarro J, Bonet A, González-Esteban J.
    Rev Esp Cardiol; 2006 Feb; 59(2):136-42. PubMed ID: 16540035
    [Abstract] [Full Text] [Related]

  • 14. Blood pressure control and target organ complications among hypertensive patients in southern Saudi Arabia.
    Ahmed ME, El-Awad IB.
    East Mediterr Health J; 2001 Feb; 7(4-5):689-96. PubMed ID: 15332767
    [Abstract] [Full Text] [Related]

  • 15. Left ventricular hypertrophy as a predictor of coronary heart disease mortality and the effect of hypertension.
    Brown DW, Giles WH, Croft JB.
    Am Heart J; 2000 Dec; 140(6):848-56. PubMed ID: 11099987
    [Abstract] [Full Text] [Related]

  • 16. [Arterial hypertension (author's transl)].
    Hartmann HG, Jutzler GA.
    Urologe A; 1981 May; 20(3):118-22. PubMed ID: 7022995
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.